This inventor holds 2 USPTO granted patents and 5 published patent applications and 2 EPO patents. Top assignees: Bayer Aktiengesellschaft, Bayer Pharma Aktiengesellschaft. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 12,268 
1 out of 387 
Years Active: 2025-2026
Title: Ulf Boemer: Innovator in Pharmaceutical Research
Introduction
Ulf Boemer is an inventor based in Glienicke, Germany. He has worked with notable companies such as Bayer Aktiengesellschaft and Deutsches Krebsforschungszentrum. Although he currently holds no granted patents, his contributions to the field of pharmaceutical research are noteworthy.
Latest Patent Applications
Ulf Boemer's latest patent applications include "Substituted Aminothiazoles as DGKzeta Inhibitors for Immune Activation." This invention covers aminothiazole compounds of general formula (I), where R, R, R, and R are defined within the application. The application details methods for preparing these compounds, intermediate compounds useful for their preparation, and pharmaceutical compositions that include these compounds. The focus is on their use for treating and preventing diseases regulated by diacylglycerol kinase zeta (DGKζ), either as a sole agent or in combination with other active ingredients.
Conclusion
Ulf Boemer's work in pharmaceutical research, particularly in the development of aminothiazole compounds, highlights his innovative approach to addressing complex medical challenges. His contributions, although not yet reflected in granted patents, demonstrate a commitment to advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile